Law360, New York (May 26, 2010, 4:22 PM EDT) -- The Federal Trade Commission has urged a federal appeals court to grant an en banc rehearing in a lawsuit over a “pay-for-delay” deal Bayer AG cut with Barr Laboratories Inc. to prevent the generic-drug maker from making its own version of the blockbuster antibiotic Cipro.
The FTC said Tuesday it voted 5-0 to approve the filing of an amicus brief on the side of the plaintiffs in the case, a group of direct purchasers.
The brief, filed May 20 in the U.S. Court of Appeals for...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.